AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 91 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $836,000 | -35.5% | 90,854 | -47.6% | 0.27% | +13.9% |
| Q2 2016 | $1,296,000 | +793.8% | 173,312 | +1443.2% | 0.24% | +1387.5% |
| Q4 2015 | $145,000 | -34.7% | 11,231 | -48.0% | 0.02% | -27.3% |
| Q2 2015 | $222,000 | +29.8% | 21,604 | +46.9% | 0.02% | +37.5% |
| Q4 2014 | $171,000 | -64.4% | 14,703 | -32.2% | 0.02% | -61.9% |
| Q3 2014 | $480,000 | – | 21,683 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |